Glaucoma-related adverse events in the infant aphakia treatment study: 1-year results

Allen D. Beck, Sharon F. Freedman, Michael J. Lynn, Erick Bothun, Daniel Neely, Scott R. Lambert

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Objectives: To report the incidence of glaucoma and glaucoma suspects in the IATS, and to evaluate risk factors for the development of a glaucoma-related adverse event in patients in the IATS in the first year of follow-up. Methods: A total of 114 infants between 1 and 6 months of age with a unilateral congenital cataract were assigned to undergo cataract surgery either with or without an intraocular lens implant. Standardized definitions of glaucoma and glaucoma suspect were created and used in the IATS. Results: Of these 114 patients, 10 (9%) developed glaucoma and 4 (4%) had glaucoma suspect, for a total of 14 patients (12%) with a glaucoma-related adverse event in the treated eye through the first year of follow-up. Of the 57patients who underwent lensectomy and anterior vitrectomy, 5 (9%) developed a glaucoma-related adverse event; of the 57 patients who underwent an intraocular lens implant, 9 (16%) developed a glaucoma-related adverse event. The odds of developing a glaucoma-related adverse event were 3.1 times higher for a child with persistent fetal vasculature and 1.6 times higher for each month of age younger at cataract surgery. Conclusions: Modern surgical techniques do not eliminate the early development of glaucoma following congenital cataract surgery with or without an intraocular lens implant. Younger patients with or without persistent fetal vasculature seem more likely to develop a glaucoma- related adverse event in the first year of followup. Vigilance for the early development of glaucoma is needed following congenital cataract surgery, especially when surgery is performed during early infancy or for a child with persistent fetal vasculature. Five-year follow- up data for the IATS will likely reveal more glaucomarelated adverse events. Trial Registration: clinicaltrials.gov Identifier: NCT00212134.

Original languageEnglish
Pages (from-to)300-305
Number of pages6
JournalArchives of Ophthalmology
Volume130
Issue number3
DOIs
StatePublished - Mar 2012

Fingerprint

Aphakia
Glaucoma
Cataract
Ocular Hypertension
Intraocular Lenses
Therapeutics
Vitrectomy

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Glaucoma-related adverse events in the infant aphakia treatment study : 1-year results. / Beck, Allen D.; Freedman, Sharon F.; Lynn, Michael J.; Bothun, Erick; Neely, Daniel; Lambert, Scott R.

In: Archives of Ophthalmology, Vol. 130, No. 3, 03.2012, p. 300-305.

Research output: Contribution to journalArticle

Beck, Allen D. ; Freedman, Sharon F. ; Lynn, Michael J. ; Bothun, Erick ; Neely, Daniel ; Lambert, Scott R. / Glaucoma-related adverse events in the infant aphakia treatment study : 1-year results. In: Archives of Ophthalmology. 2012 ; Vol. 130, No. 3. pp. 300-305.
@article{c52874a5a73540b29dff62b27f471e6b,
title = "Glaucoma-related adverse events in the infant aphakia treatment study: 1-year results",
abstract = "Objectives: To report the incidence of glaucoma and glaucoma suspects in the IATS, and to evaluate risk factors for the development of a glaucoma-related adverse event in patients in the IATS in the first year of follow-up. Methods: A total of 114 infants between 1 and 6 months of age with a unilateral congenital cataract were assigned to undergo cataract surgery either with or without an intraocular lens implant. Standardized definitions of glaucoma and glaucoma suspect were created and used in the IATS. Results: Of these 114 patients, 10 (9{\%}) developed glaucoma and 4 (4{\%}) had glaucoma suspect, for a total of 14 patients (12{\%}) with a glaucoma-related adverse event in the treated eye through the first year of follow-up. Of the 57patients who underwent lensectomy and anterior vitrectomy, 5 (9{\%}) developed a glaucoma-related adverse event; of the 57 patients who underwent an intraocular lens implant, 9 (16{\%}) developed a glaucoma-related adverse event. The odds of developing a glaucoma-related adverse event were 3.1 times higher for a child with persistent fetal vasculature and 1.6 times higher for each month of age younger at cataract surgery. Conclusions: Modern surgical techniques do not eliminate the early development of glaucoma following congenital cataract surgery with or without an intraocular lens implant. Younger patients with or without persistent fetal vasculature seem more likely to develop a glaucoma- related adverse event in the first year of followup. Vigilance for the early development of glaucoma is needed following congenital cataract surgery, especially when surgery is performed during early infancy or for a child with persistent fetal vasculature. Five-year follow- up data for the IATS will likely reveal more glaucomarelated adverse events. Trial Registration: clinicaltrials.gov Identifier: NCT00212134.",
author = "Beck, {Allen D.} and Freedman, {Sharon F.} and Lynn, {Michael J.} and Erick Bothun and Daniel Neely and Lambert, {Scott R.}",
year = "2012",
month = "3",
doi = "10.1001/archophthalmol.2011.347",
language = "English",
volume = "130",
pages = "300--305",
journal = "JAMA Ophthalmology",
issn = "2168-6165",
publisher = "American Medical Association",
number = "3",

}

TY - JOUR

T1 - Glaucoma-related adverse events in the infant aphakia treatment study

T2 - 1-year results

AU - Beck, Allen D.

AU - Freedman, Sharon F.

AU - Lynn, Michael J.

AU - Bothun, Erick

AU - Neely, Daniel

AU - Lambert, Scott R.

PY - 2012/3

Y1 - 2012/3

N2 - Objectives: To report the incidence of glaucoma and glaucoma suspects in the IATS, and to evaluate risk factors for the development of a glaucoma-related adverse event in patients in the IATS in the first year of follow-up. Methods: A total of 114 infants between 1 and 6 months of age with a unilateral congenital cataract were assigned to undergo cataract surgery either with or without an intraocular lens implant. Standardized definitions of glaucoma and glaucoma suspect were created and used in the IATS. Results: Of these 114 patients, 10 (9%) developed glaucoma and 4 (4%) had glaucoma suspect, for a total of 14 patients (12%) with a glaucoma-related adverse event in the treated eye through the first year of follow-up. Of the 57patients who underwent lensectomy and anterior vitrectomy, 5 (9%) developed a glaucoma-related adverse event; of the 57 patients who underwent an intraocular lens implant, 9 (16%) developed a glaucoma-related adverse event. The odds of developing a glaucoma-related adverse event were 3.1 times higher for a child with persistent fetal vasculature and 1.6 times higher for each month of age younger at cataract surgery. Conclusions: Modern surgical techniques do not eliminate the early development of glaucoma following congenital cataract surgery with or without an intraocular lens implant. Younger patients with or without persistent fetal vasculature seem more likely to develop a glaucoma- related adverse event in the first year of followup. Vigilance for the early development of glaucoma is needed following congenital cataract surgery, especially when surgery is performed during early infancy or for a child with persistent fetal vasculature. Five-year follow- up data for the IATS will likely reveal more glaucomarelated adverse events. Trial Registration: clinicaltrials.gov Identifier: NCT00212134.

AB - Objectives: To report the incidence of glaucoma and glaucoma suspects in the IATS, and to evaluate risk factors for the development of a glaucoma-related adverse event in patients in the IATS in the first year of follow-up. Methods: A total of 114 infants between 1 and 6 months of age with a unilateral congenital cataract were assigned to undergo cataract surgery either with or without an intraocular lens implant. Standardized definitions of glaucoma and glaucoma suspect were created and used in the IATS. Results: Of these 114 patients, 10 (9%) developed glaucoma and 4 (4%) had glaucoma suspect, for a total of 14 patients (12%) with a glaucoma-related adverse event in the treated eye through the first year of follow-up. Of the 57patients who underwent lensectomy and anterior vitrectomy, 5 (9%) developed a glaucoma-related adverse event; of the 57 patients who underwent an intraocular lens implant, 9 (16%) developed a glaucoma-related adverse event. The odds of developing a glaucoma-related adverse event were 3.1 times higher for a child with persistent fetal vasculature and 1.6 times higher for each month of age younger at cataract surgery. Conclusions: Modern surgical techniques do not eliminate the early development of glaucoma following congenital cataract surgery with or without an intraocular lens implant. Younger patients with or without persistent fetal vasculature seem more likely to develop a glaucoma- related adverse event in the first year of followup. Vigilance for the early development of glaucoma is needed following congenital cataract surgery, especially when surgery is performed during early infancy or for a child with persistent fetal vasculature. Five-year follow- up data for the IATS will likely reveal more glaucomarelated adverse events. Trial Registration: clinicaltrials.gov Identifier: NCT00212134.

UR - http://www.scopus.com/inward/record.url?scp=84858595293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858595293&partnerID=8YFLogxK

U2 - 10.1001/archophthalmol.2011.347

DO - 10.1001/archophthalmol.2011.347

M3 - Article

C2 - 22084157

AN - SCOPUS:84858595293

VL - 130

SP - 300

EP - 305

JO - JAMA Ophthalmology

JF - JAMA Ophthalmology

SN - 2168-6165

IS - 3

ER -